Updates on Aflibercept BPCIA Litigation | Insights & Resources – Goodwin Procter

10,406,226), one of its dosing regimen patents (U.S. Patent No. 10,857,205) one of its formulation patents (U.S. Patent No. … Legal Notices · Privacy …